Patents Assigned to ForDoz Pharma Corp.
  • ORAL LIQUID FORMULATIONS OF LIPID-LOWERING AND BLOOD PRESSURE-LOWERING DRUGS
    Publication number: 20240091147
    Abstract: This application discloses oral liquid formulations of lipid/cholesterol-lowering drugs and blood pressure-lowering drugs, and combinations thereof, comprising surfactant(s) as stabilizer(s), which forms micelles with the drug molecules to enhance their solubility and stability.
    Type: Application
    Filed: November 24, 2020
    Publication date: March 21, 2024
    Applicant: FORDOZ PHARMA CORP.
    Inventors: Sydney Ugwu, Zengli Fu, JAMES HE
  • INJECTABLE CONTROLLED-RELEASE FORMULATIONS OF PROGESTOGEN DRUGS
    Publication number: 20230057790
    Abstract: The present invention relates to injectable microspheres and formulations comprising the microspheres for controlled release of progestogen hormones.
    Type: Application
    Filed: February 15, 2021
    Publication date: February 23, 2023
    Applicant: FORDOZ Pharma Corp.
    Inventors: Sydney Ugwu, Zengli Fu, James He
  • INJECTABLE POLYMER NANOPARTICLE COMPOSITIONS OF ANTITHROMBOTIC AGENTS AND METHODS THEREOF
    Publication number: 20220218608
    Abstract: Disclosed are injectable nanoparticle compositions comprising a micelle formulation of an antithrombotic agent and a water-soluble, biodegradable, and amphiphilic polymer that improves water solubility of the antithrombotic agent. A method of preparing the injectable nanoparticle compositions and methods for preventing or treating thrombotic diseases such as venous thromboembolisms and/or stroke using the compositions, as well as devices and kits suitable for such treatment, are also disclosed.
    Type: Application
    Filed: May 8, 2020
    Publication date: July 14, 2022
    Applicant: FORDOZ Pharma Corp.
    Inventors: QISHENG XIN, SYDNEY UGWU, JAMES HE
  • INJECTABLE SUSTAINED-RELEASE FORMULATIONS FOR TREATMENT OF JOINT PAIN AND INFLAMMATION
    Publication number: 20220096498
    Abstract: Drug-loaded microspheres containing both a steroidal anti-inflammatory drug and a non-steroidal anti-inflammatory drug and injectable formulations containing the microspheres for sustained release of both drugs are disclosed. Methods of making such drug-loaded microspheres, formulations, and use of them for treating pains and inflammations, especially those caused by rheumatoid arthritis or osteoarthritis using such microspheres and formulations are also described.
    Type: Application
    Filed: May 6, 2020
    Publication date: March 31, 2022
    Applicant: FORDOZ Pharma Corp.
    Inventors: SYDNEY UGWU, JAMES HE, ZENGLI FU
  • Nanosome formulations of aprepitant and methods and applications thereof
    Patent number: 11260028
    Abstract: Disclosed herein are pharmaceutical formulations of aprepitant suitable for parenteral administration including intravenous administration. The pharmaceutical formulations are stable and ready-to-use liposomes for the treatment of emesis and are particularly useful for treatment of chemotherapy or surgery-induced nausea and vomiting. Methods of preparation of the aprepitant formulations are also provided.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: March 1, 2022
    Assignee: ForDoz Pharma Corp.
    Inventors: Sydney Ugwu, Xin He, Zengli Fu, Xin Teng, Ming Ji
  • NANOSOME FORMULATIONS OF APREPITANT AND METHODS AND APPLICATIONS THEREOF
    Publication number: 20200138717
    Abstract: Disclosed herein are pharmaceutical formulations of aprepitant suitable for parenteral administration including intravenous administration. The pharmaceutical formulations are stable and ready-to-use liposomes for the treatment of emesis and are particularly useful for treatment of chemotherapy or surgery-induced nausea and vomiting. Methods of preparation of the aprepitant formulations are also provided.
    Type: Application
    Filed: June 26, 2018
    Publication date: May 7, 2020
    Applicant: ForDoz Pharma Corp.
    Inventors: Sydney Ugwu, Xin He, Zengli Fu, Xin Teng, Ming Ji